The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors.
Gebregiworgis T, Kano Y, St-Germain J, Radulovich N, Udaskin ML, Mentes A, Huang R, Poon BPK, He W, Valencia-Sama I, Robinson CM, Huestis M, Miao J, Yeh JJ, Zhang ZY, Irwin MS, Lee JE, Tsao MS, Raught B, Marshall CB, Ohh M, Ikura M.
Gebregiworgis T, et al. Among authors: poon bpk.
Nat Commun. 2021 Nov 1;12(1):6274. doi: 10.1038/s41467-021-26526-y.
Nat Commun. 2021.
PMID: 34725361
Free PMC article.